ReGen Valley Tech Hub
Lead Agency: Advanced Regenerative Manufacturing Institute
State Served: New Hampshire
Region: Manchester-Nashua MSA
Core Technology Area: biofabrication
Contact: Julie Lenzer ([email protected])
Media Contact: Jennifer MacDonald ([email protected])
The ReGen Valley Tech Hub, led by the Advanced Regenerative Manufacturing Institute (ARMI), aims to make New Hampshire a global leader in biofabrication to produce cost-effective regenerative therapies that address chronic disease and organ failure. Amidst growing commercial demand for these therapies and building on its EDA Build Back Better Regional Challenge award, this Tech Hub aims to advance biofabrication-related therapies, train critical workforce, and invest in manufacturing facilities to secure domestic regenerative therapy development and biofabrication.
In July 2024, EDA recommended this Tech Hub receive grant funding of approximately $44 million to implement five projects, including:
-
Scaling commercialization capacity by building on foundational manufacturing, regulatory, and commercialization resources;
-
Creating a multi-institution Common Campus model to meet biofabrication workforce needs through retaining, developing, and attracting talent;
-
Increasing awareness and adoption of regenerative therapies among clinicians and the public through training and outreach events;
-
Scaling a paid apprenticeship training program to fill workforce gaps, and provide childcare spaces for the biofabrication industry’s workforce; and
-
Driving consortium-wide engagement through training, policy adoption, and dispute resolution while also collecting and ensuring metrics, outcomes, and broader impacts are equitably distributed and efforts are driving inclusive growth.
To ensure that the impacts of the Tech Hub project benefit the entire region, the consortium is committed to engaging underrepresented community voices in governance, including labor unions, workers, and businesses owned by underrepresented founders. Additionally, ReGen Valley Tech Hub will focus on health equity and strive for equity in clinical trials, therapy distribution, and access.
Designee Narrative (PDF) (submitted by the designee in its Phase 2 application package)
Additional Designations Earned in Region